Susana Puig

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà et al. · New England Journal of Medicine · 2018 · 1.9K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Human–computer collaboration for skin cancer recognition

Philipp Tschandl, Zoé Apalla, Giuseppe Argenziano et al. · Nature Medicine · 2020 · 912 citations · Full text

Computing, Computer Science, Dermatology +13

Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study

Philipp Tschandl, Noel Codella, Bengü Nisa Akay et al. · The Lancet Oncology · 2019 · 539 citations · Full text

Medicine, Dermatology, Health Informatics +16

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano et al. · Nature · 2011 · 522 citations

Medicine, Genetics, Oncology +14

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

May Chan, Mark Harland, Nicholas K. Hayward et al. · Journal of Medical Genetics · 2006 · 475 citations · Full text

Life Sciences, Genetics, Oncology +17